Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
05/13/1987 | EP0221700A2 A thrombin preparation |
05/13/1987 | EP0221588A2 Brain-specific drug delivery |
05/13/1987 | EP0221566A2 Method for preparing antihemophilic factor (AHF) by cold precipitation and for improving solubility of recovered AHF product |
05/13/1987 | EP0221561A2 Antigen indicative of human breast cancer and assays based thereon |
05/13/1987 | EP0221426A2 Method of preparing alpha-1-proteinase inhibitor |
05/13/1987 | EP0221173A1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof |
05/12/1987 | US4665192 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole |
05/12/1987 | US4665189 Oxiranes |
05/12/1987 | US4665161 Process for producing highly purified HCG |
05/12/1987 | US4665159 High titer varicella-zoster immune globulin for intravenous administration |
05/12/1987 | US4665158 Method for hydrolyzing protein materials |
05/12/1987 | US4665157 Oligopeptide analgesics |
05/12/1987 | US4665055 Peptide renin inhibitors |
05/12/1987 | US4665054 Glycyl-histidyl-lysine copper chelate |
05/12/1987 | US4665053 Hydrophobic carboxylic modifier |
05/12/1987 | US4665052 Homophenylalanine, hypotensives, antialdosterones |
05/12/1987 | CA1221635A1 Composition with an improved pharmaceutical activity and use as veterinary drug |
05/07/1987 | WO1987002697A1 Supercritical fluid extraction of animal derived materials |
05/07/1987 | WO1987002677A1 Isoforms of soluble immune response suppressor |
05/07/1987 | WO1987002676A1 Conformationally constrained oxytocin antagonists with prolonged biological activities |
05/07/1987 | WO1987002675A1 Difluorocyclostatine containing polypeptides |
05/07/1987 | WO1987002674A1 Analogs of atrial natriuretic peptides |
05/07/1987 | WO1987002673A2 Process for activating heterologous, eucaryotic proteins genetically engineered and presenting disulphide bridges after their expression in procaryotic cells |
05/07/1987 | WO1987002671A1 Modular assembly of antibody genes, antibodies prepared thereby and use |
05/07/1987 | WO1987002585A2 Treating increased intraocular pressure caused by steroids |
05/07/1987 | WO1987002581A1 Renin inhibitors and methods for using same |
05/06/1987 | EP0221019A2 Peptides |
05/06/1987 | EP0220958A2 Selective chemical removal of a protein amino-terminal residue |
05/06/1987 | EP0220957A2 Platelet binding inhibitors |
05/06/1987 | EP0220899A1 Bifunctional linker |
05/06/1987 | EP0220865A2 Lactam derivatives, their preparation and their use as hypotensive agents |
05/06/1987 | EP0220665A2 Peptides |
05/06/1987 | EP0220657A2 Conjugate of 9-(2-hydroxyethoxymethyl)-guanine with lactosaminated human albumin, process for the peparation thereof and pharmaceutical compositions containing it |
05/06/1987 | EP0220654A2 Gonadoliberine analogues, process for preparing them, pharmaceutical composition and use |
05/06/1987 | EP0220574A1 Human interferon beta2A, vectors containing genes coding for said interferon, cell lines producing same |
05/06/1987 | EP0220537A1 Pharmaceutical composition containing thymus extract fractions |
05/06/1987 | EP0220482A1 Novel plasmid and use thereof |
05/06/1987 | EP0220309A1 Method for augmenting immune response |
05/06/1987 | EP0220308A1 Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods |
05/06/1987 | CN85107873A Monoclonal antibodies against metal chelates |
05/05/1987 | US4663438 Novel nucleic acid-containing glycoprotein |
05/05/1987 | US4663437 Atrial natriuretic peptide |
05/05/1987 | US4663435 Release inhibitors for hormones, insulin |
05/05/1987 | US4663342 Antitumor |
05/05/1987 | US4663310 Renin inhibitors containing 2-substituted statine |
05/05/1987 | US4663309 Novel peptide hormones with calcitonin-like activity |
05/05/1987 | US4663164 Aqueous compositions for treating blood clotting factor inhibitors |
04/29/1987 | EP0220157A2 Mitogenic peptides |
04/29/1987 | EP0220107A2 Use of angiotensin-converting enzyme inhibitors in macular degeneration |
04/29/1987 | EP0220030A2 Oral delivery system |
04/29/1987 | EP0219979A2 Treating animals using IL-2, formulations therefor and their preparation |
04/29/1987 | EP0219874A2 Process for activating recombinant heterologous eucaryotic disulfide-bridged proteins after expression by procaryotes |
04/29/1987 | EP0219839A2 Interleukin-2 derivative, its preparation and use |
04/29/1987 | EP0219782A2 Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease |
04/29/1987 | EP0219781A2 Biologically active human gamma interferon derivatives, their preparation and drugs containing such derivatives |
04/29/1987 | EP0219716A2 Immunosuppressive agent |
04/28/1987 | US4661586 Monoclonal anti-idiotype antibodies |
04/28/1987 | US4661479 Enzyme inhibitors |
04/28/1987 | US4661473 Hypotensive agents |
04/28/1987 | US4661472 GnRH antagonists IX |
04/28/1987 | US4661471 Administering low molecular weight peptide |
04/28/1987 | US4661470 Ester derivatives of antibiotic L 17046 |
04/28/1987 | US4661469 t-PA composition capable of being absorbed into the blood stream and method of administration |
04/28/1987 | US4661347 Cytotoxic compositions |
04/28/1987 | US4661346 Immunological compositions including a peptide and osmium or ruthenium tetroxide |
04/28/1987 | CA1221030A1 Allograft of reduced immunogenicity and method and reagent for making same |
04/28/1987 | CA1221029A1 Plasminogen activator, its preparation process and thrombolytic agent containing same |
04/28/1987 | CA1221028A1 Material for use in the treatment of spontaneous abortions |
04/23/1987 | WO1987002384A1 Expression systems for overproduction of desired proteins |
04/23/1987 | WO1987002368A1 New mammal protein having an immunomodulating and progestational activity |
04/23/1987 | WO1987002251A1 Oral delivery of biologically active substances bound to vitamin b12, or analogues thereof |
04/23/1987 | WO1987002247A1 Rapid acting intravenous emulsions of omega-3 fatty acid esters |
04/23/1987 | WO1987002243A1 A composition for treating and preventing diarrhoea in humans andanimals and a method of preparing same |
04/23/1987 | WO1987002219A1 Alpha tocopherol-based vesicles |
04/23/1987 | DE3537460A1 Derivatives of bicyclic amino acids, process for their preparation, compositions containing these and their use |
04/22/1987 | EP0219400A1 Glycopeptides and glycoproteins, any composition containing them, method for their preparation, and anticoagulation applications thereof |
04/22/1987 | EP0219295A2 Process for producing human growth hormone |
04/22/1987 | EP0219275A2 Vasopressin compounds |
04/22/1987 | EP0219270A2 Method of enhancing tissue plasminogen activator and single chain urokinase plasminogen activator production |
04/22/1987 | EP0219258A2 Peptide antagonists of Neurokinin B and opthalmic solutions containing them |
04/22/1987 | EP0219106A2 Polypeptides that elicit antibodies against AIDS virus |
04/22/1987 | EP0219073A2 Stabilization of interferons |
04/22/1987 | EP0218900A2 Osmotic agents for peritoneal dialysis |
04/22/1987 | EP0218868A2 Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor |
04/22/1987 | EP0218825A1 Cysteine-depleted muteins of interferon-beta, their preparation, formulations containing them, and structural genes, vectors and organisms, and their production, suitable for use in the preparation of said muteins |
04/22/1987 | EP0218717A1 Recombinant inhibin |
04/22/1987 | EP0218696A1 Human anti-inflammatory phospholipase inhibitor protein |
04/22/1987 | EP0218692A1 Von willebrand factor |
04/22/1987 | EP0218650A1 Pharmacologically active peptides |
04/21/1987 | US4659805 Recombinant alveolar surfactant protein |
04/21/1987 | US4659804 (Bis-1,7-S-acetamidomethyl-L-cysteine)salmon calcitonin |
04/21/1987 | US4659695 Method of treatment of prostate cancer |
04/21/1987 | US4659694 Polypeptide hormone for prevention of infections |
04/21/1987 | US4659692 Cationic oligopeptides having microbicidal activity |
04/21/1987 | US4659691 Novel cyclic Hexapeptide LHRH antagonists |
04/21/1987 | US4659660 Culturing streptomyces toyocaensis nrrl under submerged aerobic fermentation conditions |
04/21/1987 | US4659570 Preparation containing stabilized physiologically active substance |
04/21/1987 | US4659563 High titer anti-respiratory syncytial virus intravenous immune globulin |
04/21/1987 | US4658830 Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms |
04/21/1987 | CA1220746A1 Luzopeptin e.sub.2 |